Abstract:Objective To investigate the protective effect of indole-3-carbinol (I3C) on radiation-induced mouse bone marrow hematopoietic cell injury and the involved mechanisms. Methods (1) The bone marrow nuclear cells (BMNCs) from CD45.1 subtype of C57BL/6J mice were collected by a density gradient centrifugation method. The BMNCs were pretreated with a series doses of I3C (0 mol/L, 10-8 mol/L-10-3 mol/L) and then exposed with radiation of 137Csγ-ray (doses of irradiation were 0 Gy, 1 Gy and 4 Gy). After 18-hour culturing, the bioluminescence method was used to detect the cell viability. (2) These cells were divided into control group and 10-6 mol/L I3C group. Both groups were received the irradiation (0 Gy, 1 Gy and 4 Gy) and inoculated into the methylcellulose semi-solid culture medium to incubate 7 days, the colony forming unit-granulocyte monocytes (CFU-GM) were observed. (3) Twenty-four CD45.2 subtype mice used as the receptor were exposed with 8 Gy radiation. The CD45.1 BMNCs were divided into control group, 4 Gy irradiation group, 4 Gy irradiation and 10-6 mol/L I3C group. Donor cells were harvested from C57BL/6J (CD45.1) mice after they received various treatments, and were then mixed with competitive BMNCs from C57BL/6J (CD45.2) mice. The mixed cells were transplanted into recipient mice (8 mice/group). Flow cytometry was used to analyze the proportion of donor cells in peripheral blood of receptor. (4) The cells were divided into control group, 10-6 mol/L I3C group, 1 Gy irradiation group, 1 Gy irradiation with 10-6 mol/L I3C group. After 24-hour culturing, Western blot assay was used to detect the expression levels of nuclear factor erythroid 2-related factor 2 (Nrf2) and hemeoxygenase-1 (HO-1). Results (1) I3C showed a significant cytotoxic effect on the BMNCs when its concentration was above 10-4 mol/L. 10-7-10-6 mol/L I3C could reduce the radiation injury of BMNCs under the same dose of irradiation. Therefore, 10-6 mol/L I3C was chosen for subsequent experiments. (2) The CFU-GM was significantly higher in 10-6 mol/L I3C group than that of control group (P<0.05). (3) Results of flow cytometry showed that the proportion of donor cells in receptor was significantly higher in 4 Gy irradiation group than that of control group, which decreased the engraftment capability of irradiated HSCs (P<0.05), although the engraftment capability of irradiated HSCs improved after 10-6 mol/L I3C treatment. (4) I3C significantly enhanced the increased protein expression of Nrf2 and HO-1 caused by radiation (P<0.05). Conclusion I3C has a protective effect on hematopoietic cells following radiation-induced injury, which may be related with activating the Nrf2/HO-1 signal pathway.

Effect of Recombinant Human Interleukin -11 on Radiation Injury of Small Intestinal Epithelial Cell

Icotinib Hydrochloride Enhances Chemo- And Radiosensitivity By Inhibiting Egfr Signaling And Attenuating Rad51 Expression And Function In Hela S3 Cells

[An Experimental Study of the Effect of IL-2 on the Growth of Irradiated Intestinal Epithelial Cells].

The safety and efficacy of interleukin 11 for radiation injury

Effects of Recombinant Human Interleukin-11 on Animal Chemotherapeutic Thrombocytopenia

The therapeutic utility of Interleukin-11 in the treatment of inflammatory disease

Protective machanism of rhIL-11 against radiation lung injury: inhibiting TNF-α and enhancing MnSOD mRNA accumulation G

Recombinant human interleukin-11 for treatment of chemotherapy-induced thrombocytopenia in patients with gastrointestinal cancer

Efficacy and safety of recombinant human interleukin-11 for the treatment of thrombocytopenia after chemotherapy: a Meta-analysis

Study on the Therapeutic Effect of Cytokine on Acute Radiation Syndrome Induced by 60Co γ Ray Exposure

Clinical Analysis of Recombinant Human Interleukin-11 in Treatment of Chemotherapy-Induced Thrombocytopenia in Patients with Malignant Tumors

The effect and mechanism of indole-3-carbinol on alleviating the radiation-induced bone marrow hematopoietic cell injury in mice

Efficacy And Safety Of Recombinant Human Interlerukin-11 In The Treatment Of Chemotherapy-Induced Thrombocytopenia In Acute Lymphoblastic Leukemia

Effects on regulation of GSK3 β coupled signaling transduction pathway in radiation-induced apoptosis of IEC-6 cells

Effect of recombinant human interleukin 11 on thrombocytopenia induced by chemotherapy in patient with acute lymphoblastic leukemia

Microbiota-derived I3A protects the intestine against radiation injury by activating AhR/IL-10/Wnt signaling and enhancing the abundance of probiotics

Efficacy of recombinant human interleukin-11 in preventing and treating oral mucositis after chemotherapy for patients with acute leukemia

Effect of IL-11 in Prevention and Treatment of Oral Mucosal Complications of Radiotherapy for Head and Neck Cancer

Radiation-Induced Intestinal Injury: Injury Mechanism and Potential Treatment Strategies.

Comparison of the Effects of the Pretreatment and Treatment with RhIL-11 on Acute Liver Failure Induced by D-galactosamine.

Effects of Recombinant Human IL-11 on the Formation of Mouse-Tail Scale Epidermis Granular Layer and the Level of IL-2 in Serum